In addition, once you have scheduled your consultation, you will be invited to join our private TouchMD website where patient education videos, before and after pictures and more information about our office is available to you prior to your appointment.
15g protein and it handles a chocolate craving without a detour to the pantry
Lilly submitted the diabetes NDA in October 2021, the FDA approved Mounjaro in May 2022, and the obesity approval (Zepbound) followed in November 2023
Introduction to the GLP-1 Vision Loss Lawsuit: GLP-1 Vision Loss Lawsuit: Refers to the massive tidal wave of lawsuits being commenced by individuals taking GLP-1 drugs (Ozempic, Saxenda, Zepbound, Trulicity, Wegovy, etc.) who have suffered severed GLP-1 vision side effects including permanent vision loss and are now filing multiple lawsuits against the manufactures
To identify potential metabolic alterations associated with ovarian aging, we reanalyzed a previously published ovarian metabolomic dataset 15 , which revealed a pronounced decrease in uridine and its downstream metabolites in aged mice compared with young controls (Fig
While intriguing, these benefits lack robust clinical backing, and their consistency is uncertain